MAO-B-IN-28, identified by its CAS number 3028096-72-9, is a selective inhibitor of the enzyme monoamine oxidase B (MAO-B). This enzyme is involved in the breakdown of neurotransmitters such as dopamine, and its inhibition can have significant implications for neurological health, particularly in the context of neurodegenerative diseases like Parkinson's disease. The compound is characterized by its ability to enhance dopaminergic activity, potentially leading to improved motor function and cognitive performance in affected individuals. MAO-B-IN-28 is typically studied for its pharmacological properties, including its potency, selectivity, and safety profile. As a research chemical, it may also exhibit specific interactions with other biological targets, influencing its therapeutic potential. However, detailed information regarding its solubility, stability, and metabolic pathways would require further empirical investigation. Overall, MAO-B-IN-28 represents a promising avenue for the development of treatments aimed at modulating monoamine levels in the brain.

MAO-B-IN-28

3028096-72-9: MAO-B-IN-28, identified by its CAS number 3028096-72-9, is a selective inhibitor of the enzyme monoamine oxidase B (MAO-B). This enzyme is involved in the breakdown of neurotransmitters such as dopamine, and its inhibition can have significant implications for neurological health, particularly in the context of neurodegenerative diseases like Parkinson's disease. The compound is characterized by its ability to enhance dopaminergic activity, potentially leading to improved motor function and cognitive performance in affected individuals. MAO-B-IN-28 is typically studied for its pharmacological properties, including its potency, selectivity, and safety profile. As a research chemical, it may also exhibit specific interactions with other biological targets, influencing its therapeutic potential. However, detailed information regarding its solubility, stability, and metabolic pathways would require further empirical investigation. Overall, MAO-B-IN-28 represents a promising avenue for the development of treatments aimed at modulating monoamine levels in the brain.

<p>MAO-B-IN-28 (compound 10e) is a potent hMAO-B inhibitor with an IC50 value of 1.9±0.5 nM, potentially serving as a candidate molecule for neurodegenerative disease research.</p>

CAS 3028096-72-9

MAO-B-IN-28

MAO-B-IN-28

Ref: TM-T208337